New Niaspan Tablets Gain FDA Approval
This article was originally published in The Pink Sheet Daily
Executive Summary
Coated tablet version of Abbott’s cholesterol therapy reduces flushing, firm claims.
You may also be interested in...
Abbott Won’t Shrink From Competitor Merck’s Cordaptive
Merck’s niacin/laropiprant combination will compete against Abbott’s Niaspan after it is approved by FDA.
Abbott Won’t Shrink From Competitor Merck’s Cordaptive
Merck’s niacin/laropiprant combination will compete against Abbott’s Niaspan after it is approved by FDA.
Abbott Files Simcor With FDA
Combination of niacin and simvastatin will address LDL, HDL and triglycerides in a single pill.